Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
Public ClinicalTrials.gov record NCT01456013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Contrast-Induced Nephropathy (CIN) can occur when patients with pre-existing kidney problems undergo procedures that use iodinated contrast media, such as cardiac catheterizations. RenalGuard Therapy was developed to enable the patient to clear the contrast out of their kidney before it can do significant damage. This study aims to enroll patients with increased risk of developing CIN who are scheduled for a cardiovascular catheterization. Patients will be randomized to either RenalGuard therapy or standard therapy.
Study identification
- NCT ID
- NCT01456013
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 326 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2012 (Type not available)
- Primary completion
- Mar 2018 (Actual)
- Completion
- Dec 2024 (Estimated)
- Last update posted
- Feb 16, 2023
2012 – 2024
United States locations
- U.S. sites
- 30
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35924 | — |
| Torrance Medical Center | Torrance | California | 90505 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Clearwater Cardiovascular | Clearwater | Florida | 33756 | — |
| University of Florida | Jacksonville | Florida | 32209 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Advocate Good Samaritan | Downers Grove | Illinois | 60515 | — |
| Advocate Health | Naperville | Illinois | 65040 | — |
| Johns Hopkins University | Baltimore | Maryland | 21218 | — |
| St. Elizabeth's Hospital | Brighton | Massachusetts | 02135 | — |
| Cape Cod Healthcare | Hyannis | Massachusetts | 02601 | — |
| University of Massachusetts | Worcester | Massachusetts | 01655 | — |
| Northern Michigan Hospital | Petoskey | Michigan | 49770 | — |
| Abbott Northwestern | Minneapolis | Minnesota | 55407 | — |
| North Mississippi Medical Center | Tupelo | Mississippi | 38801 | — |
| St. Joseph Medical Center | Saint Charles | Missouri | 63301 | — |
| NYU Medical Center | New York | New York | 10016 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Columbia University | New York | New York | 10032 | — |
| Montefiore Medical Center | New York | New York | 10467 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794 | — |
| Rex Hospital | Raleigh | North Carolina | 27607 | — |
| St. John Research Institute | Bartlesville | Oklahoma | 74006 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Guthrie Medical Center | Sayre | Pennsylvania | 18840 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| The Miriam Hospital | Providence | Rhode Island | 02906 | — |
| Austin Heart Central | Austin | Texas | 78756 | — |
| Baylor Scott & White | Plano | Texas | 75093 | — |
| Austin Heart Round Rock | Round Rock | Texas | 78681 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01456013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01456013 live on ClinicalTrials.gov.